Aditya P. Mohanty - 15 May 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role: Chief Executive Officer, Director
Signature: /s/ Will Pridgen, Attorney-in-Fact for Aditya P. Mohanty
Issuer symbol: BIORQ
Transactions as of: 15 May 2022
Net transactions value: $0
Form type: 4
Filing time: 17 May 2022, 17:19:35 UTC
Previous filing: 15 Nov 2021
Next filing: 16 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOR	Common Stock	Award	$0	+1,562,500	+111%	$0.000000	2,974,929	15 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOR	Stock Option (Right to Buy)	Award	$0	+2,495,425		$0.000000	2,495,425	15 May 2022	Common Stock	2,495,425	$0.7500	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 1,562,500 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
F2	This option represents the right to purchase 2,495,425 shares of the Issuer's common stock, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal monthly installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.